187 related articles for article (PubMed ID: 7094510)
21. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
[TBL] [Abstract][Full Text] [Related]
22. Gas-chromatographic analysis for therapeutic concentrations of amitriptyline and nortriptyline in plasma, with use of a nitrogen detector.
Bailey DN; Jatlow PI
Clin Chem; 1976 Jun; 22(6):777-81. PubMed ID: 1277461
[TBL] [Abstract][Full Text] [Related]
23. Contribution of the variants of alpha 1-acid glycoprotein to its binding of drugs.
Baumann P; Eap CB
Prog Clin Biol Res; 1989; 300():379-97. PubMed ID: 2674972
[No Abstract] [Full Text] [Related]
24. Toxicokinetics of nortriptyline and amitriptyline: two case reports.
Franssen EJ; Kunst PW; Bet PM; Strack van Schijndel RJ; van Loenen AC; Wilhelm AJ
Ther Drug Monit; 2003 Apr; 25(2):248-51. PubMed ID: 12657923
[TBL] [Abstract][Full Text] [Related]
25. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
Nordin C; Bertilsson L; Siwers B
Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
[TBL] [Abstract][Full Text] [Related]
26. Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response.
Vandel B; Vandel S; Allers G; Bechtel P; Volmat R
Psychopharmacology (Berl); 1979 Oct; 65(2):187-90. PubMed ID: 42101
[No Abstract] [Full Text] [Related]
27. Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.
Coppen A; Ghose K; Montgomery S; Rama Rao VA; Bailey J; Christiansen J; Mikkleson PL; van Praag HM; van de Poel F; Minsker EJ; Kozulja VG; Matussek N; Kungkunz G; Jłrgensen A
Lancet; 1978 Jan; 1(8055):63-6. PubMed ID: 74566
[TBL] [Abstract][Full Text] [Related]
28. The use of therapeutic drug monitoring data to document kinetic drug interactions: an example with amitriptyline and nortriptyline.
Jerling M; Bertilsson L; Sjöqvist F
Ther Drug Monit; 1994 Feb; 16(1):1-12. PubMed ID: 7909176
[TBL] [Abstract][Full Text] [Related]
29. Steady-state concentrations of amitriptyline and its metabolite nortriptyline in Saudi patients.
el-Yazigi A; Chaleby K
Ther Drug Monit; 1987; 9(1):6-10. PubMed ID: 3576661
[TBL] [Abstract][Full Text] [Related]
30. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
Jungkunz G; Kuss HJ
Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
[TBL] [Abstract][Full Text] [Related]
31. Distribution of moricizine in human blood: binding to plasma proteins and erythrocytes.
Yang JM; Chan K; Chiang WT
Ther Drug Monit; 1990 Jan; 12(1):59-64. PubMed ID: 1689514
[TBL] [Abstract][Full Text] [Related]
32. Correlations between serum ami- and nortriptyline concentrations and psychomotor performance.
Seppälä T; Liljequist R; Linnoila M; Overo KF; Dorrity F
Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):472-80. PubMed ID: 579558
[TBL] [Abstract][Full Text] [Related]
33. Determination of free fractions of tricyclic antidepressants.
Nyberg G; Mårtensson E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):260-5. PubMed ID: 6493364
[TBL] [Abstract][Full Text] [Related]
34. Quality control of amitriptyline and nortriptyline plasma level assessments: a multicenter study.
Baumann P; Breyer-Pfaff U; Kuss HJ; Müller-Oerlinghausen B; Sandoz M
Pharmacopsychiatria; 1982 Sep; 15(5):156-60. PubMed ID: 7178230
[TBL] [Abstract][Full Text] [Related]
35. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
[TBL] [Abstract][Full Text] [Related]
36. Plasma protein binding of perazine and amitriptyline in psychiatric patients.
Brinkschulte M; Gaertner HJ; Schied HW; Breyer-Pfaff U
Eur J Clin Pharmacol; 1982; 22(4):367-73. PubMed ID: 6125396
[TBL] [Abstract][Full Text] [Related]
37. The demethylation of amitriptyline administered by oral and intramuscular routes.
Burch JE; Herries DG
Psychopharmacology (Berl); 1983; 80(3):249-53. PubMed ID: 6412269
[TBL] [Abstract][Full Text] [Related]
38. Amitriptyline and amitriptyline metabolites in blood and cerebrospinal fluid following human overdose.
Hultén BA; Heath A; Knudsen K; Nyberg G; Svensson C; Mårtensson E
J Toxicol Clin Toxicol; 1992; 30(2):181-201. PubMed ID: 1588668
[TBL] [Abstract][Full Text] [Related]
39. Differences in the binding of quinine and quinidine to plasma proteins.
Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
[TBL] [Abstract][Full Text] [Related]
40. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
Zini R; Morin D; Salvadori C; Tillement JP
Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
